These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24698250)

  • 1. CABG versus PCI in diabetic patients with multivessel disease after risk stratification by the SYNTAX score: a pooled analysis of the SYNTAX and FREEDOM trials.
    Capodanno D; Capranzano P; Tamburino C
    Int J Cardiol; 2014 May; 173(3):548-9. PubMed ID: 24698250
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials.
    Campos CM; Garcia-Garcia HM; van Klaveren D; Ishibashi Y; Cho YK; Valgimigli M; Räber L; Jonker H; Onuma Y; Farooq V; Garg S; Windecker S; Morel MA; Steyerberg EW; Serruys PW
    Int J Cardiol; 2015; 187():111-5. PubMed ID: 25828327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).
    Biancari F; Gudbjartsson T; Heikkinen J; Anttila V; Mäkikallio T; Jeppsson A; Thimour-Bergström L; Mignosa C; Rubino AS; Kuttila K; Gunn J; Wistbacka JO; Teittinen K; Korpilahti K; Onorati F; Faggian G; Vinco G; Vassanelli C; Ribichini F; Juvonen T; Axelsson TA; Sigurdsson AF; Karjalainen PP; Mennander A; Kajander O; Eskola M; Ilveskoski E; D'Oria V; De Feo M; Kiviniemi T; Airaksinen KE
    Am J Cardiol; 2014 Jul; 114(2):198-205. PubMed ID: 24878127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2.
    Tazaki J; Shiomi H; Morimoto T; Imai M; Yamaji K; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    EuroIntervention; 2013 Aug; 9(4):437-45. PubMed ID: 23965348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ J; 2015; 79(6):1282-9. PubMed ID: 25818902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
    Bangalore S; Toklu B; Feit F
    Circ Cardiovasc Interv; 2014 Aug; 7(4):518-25. PubMed ID: 24939927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Hayano M; Furukawa Y; Nakagawa Y; Tazaki J; Imai M; Yamaji K; Tada T; Natsuaki M; Saijo S; Funakoshi S; Nagao K; Hanazawa K; Ehara N; Kadota K; Iwabuchi M; Shizuta S; Abe M; Sakata R; Okabayashi H; Hanyu M; Yamazaki F; Shimamoto M; Nishiwaki N; Imoto Y; Komiya T; Horie M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2012 Oct; 110(7):924-32. PubMed ID: 22721575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.
    Taggart DP
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):978-9. PubMed ID: 24047712
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.